A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 580-588

  Hann, I ^a   Viscoli, C ^b   Paesmans, M ^c   Gaya, H ^d   Glauser, M ^e  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GENOA   (Italy)

^c JULES BORDET INSTITUTE   (Belgium)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Children; Febrile; Infection; Neutropenia; Prognosis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTEREMIA; CHILD; CONTROLLED STUDY; FEVER; HODGKIN DISEASE; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0030701941     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4453255.x     Document Type: Article

References (26)

1. Bash, B.O., Katz, J.A., Cash, J.V. & Buchanan, G.R. (1994) Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer, 74, 189-196.
2. Blay, J., Chauvin, F., LeCesne, A., Anglaret, B., Bonhour, D., Lasset, C. Freyer, C., Philip, T. & Biron, P. (1996) Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neturopenia. Journal of Clinical Oncology, 14, 636-645.
3. Bodey, G.P., Buckley, M. Sathe, Y.S. & Freireich, E.J. (1966) Quantitative relationships between circulating leukocytes and infections in patients with acute leukaemia. Annals of Internal Medicine, 64, 328-340.
4. Buchanan, G.R. (1993) Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematology/Oncology Clinics of North America, 7, 919-935.
5. Cometta, A., Calandra, T., Gaya, H., Zinner, S.H., DeBock, R., Del Favero, A., Bucaneve, G., Grokaert, F. Kern, W.V., Klastersky, J., Langenacken, J., Micozzi, A., Padmos, A., Paesmans, M., Viscoli, C., Glanser, M.P. and IATCC, of the EORTC (1996) Monotherapy with meropeneum versus combination therapy with ceftazidime plus amikacin as empiric therapy for lever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy, 40, 1108.
6. Cometta, A., Zinner, S., de Bock, R., Calandra, T., Gaya, H., Klastersky, K., Langenaeken, J., Paesmans, M., Viscoli, C. & Glauser, M.P. (1995) Piperacillin-Tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy, 59, 445-452.
7. EORTC International Antimicrobial Therapy Cooperative Group (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. New England Journal of Medicine, 317, 1692-1698.
8. EORTC International Antimicrobial Therapy Cooperative Group (1993) Efficacy and toxicity of single daily dose of amikacin and ceftrixone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine, 119, 584-593.
9. EORTC International Antimicrobial Therapy Cooperative Group & National Cancer Institute of Canada - Clinical Trials Group (1991) Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. Journal of Infectious Diseases, 163, 951-958.
10. Griffin, T.C. & Buchanan, G.R. (1992) Hematologic predictors of bone marrow recovery in neutropenic patients hospitalised for fever: implications for discontinuation of antibiotics and early discharge from hospital. Journal of Pediatrics, 121, 28-33.
11. Johnson, C.C. & Tunkel, A.R. (1995) Viridans streptococci and groups C and G streptococci. Principles and Practice of Infectious Diseases (ed. by G. L. Mandell, J. E. Bennett and R. Dolin), p.1849. Churchill Livingstone, New York.
12. Jones, G.R., Konsler, G.K. & Pusek, S.N. (1996) Infection risk factors in febrile, neutropenic children and adolescents. Pediactric Hematology and Oncology, 13, 217-229.
13. Kosmidis, H.V., Lusher, J.M. & Shope, T.C. (1980) Infections in leukaemic children, a prospective analysis. Journal of Pediatrics, 96, 407-412.
14. Lie, S.O. (1995) Treatment of acute myeloid leukaemia in children. Leukaemia and Lymphoma (ed. by J. M. Chessells and I. M. Hann), p. 757. Bailliere Tindall, London.
15. Lilleyman, J.S. & Hann, I.M. (1995) Management of acute lymphoblastic leukaemia. Leukaemia and Lymphoma (ed. by J. M. Chessells and I. M. Hann), p. 779. Bailliere Tindall, London.
16. Lucas, K.G., Brown, A.H., Armstrong, D., Chapman, D. & Heller, G. (1996) The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteraemia and complications of sepsis. Cancer, 77, 791-798.
17. Meunier, F., Zinner, S.H., Gaya, H., Calandra, T., Viscoli, C. & Klastersky, J. (1991) Prospective randomized evaluation of ciprofloxeicin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumours. Antimicrobial Agents and Chemotheraphy, 35, 873-878.
18. Mullen, C.A. & Buchanan, C.R. (1990) Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. Journal of Clinical Oncology, 8, 1998-2004.
19. Rackoff, W.R., Gonin, R., Robinson, C., Kreissman, S.G. & Breitfeld, P.P. (1997) Predicting the risk of bacteremia in children with fever and neutropenia. Journal of Clinical Oncology, 14, 919-924.
20. Robinson, L.L. & Ross, J.A. (1945) Epidemiology of leukaemias and lymphomas in childhood. Leukaemia and Lymphoma (ed. by J. M. Chessells and I. M. Hann), p. 639. Bailliere Tindall, London.
21. Rubenstein, E.B., Rolston, K. & Benjamin, R.S. (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer, 71, 3640.
22. Talcott, J.A., Finberg, R., Mayer, R.J. & Goldman, L. (1988) The medical course of cancer patients with lever and neutropenia: clinical identification of a low-risk group at presentation. Archives of Internal Medicine, 148, 2561.
23. Talcolt, J.A., Siegel, R.D., Finberg, R. & Goldman, L. (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective two-centre validation of a prediction rule. Journal of Clinical Oncology, 10, 316.
24. Talcott, J.A., Whale, A., Clark, J., Ricker, P.P. & Finberg, R. (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. Journal of Clinical Oncology, 12, 107.
25. Viscoli, C., Bruzzi, P., Castagnola, E., Boni, L., Calandra, T., Gaya, H., Meunier, F., Feld, R., Zinner, S., Klastersky, J. & Glauser, M. (1994) Factors associated with bacteremia in febrile granulocytopenic cancer patients. European Journal of Cancer, 30, 430-437.
26. Wade, J.C., Schimpff, S.C., Newman, K.A. & Wiernik, P.H. (1982) Stephylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine, 97, 503-508.